James B. Tananbaum Kinnate Biopharma Inc. (KNTE) insider trading activity

KNTE Quotes by TradingView

James B. Tananbaum Transaction History

Date Transaction Value Shares Traded Form
Apr 03 2024
SELL
Sale (or disposition) back to the issuer
-
13,718,311
May 08 2023
BUY
Open market or private purchase
$4,984,000 $2.8 p/Share
1,780,000
Feb 17 2023
BUY
Other acquisition or disposition
-
1,100,000
Dec 07 2020
BUY
Conversion of derivative security
-
9,838,311
Dec 03 2020
BUY
Open market or private purchase
$20,000,000 $20.0 p/Share
1,000,000

Also insider at

QSI
Quantum-Si Inc Healthcare
Director
PRDS
PARDES BIOSCIENCES, INC. Healthcare
President and CEO
GMTX
Gemini Therapeutics, Inc. Healthcare
Director
ALMS
ALUMIS INC.
Director
JBT

James B. Tananbaum

San Diego, CA

Track Institutional and Insider Activities on KNTE

Follow Kinnate Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNTE shares.

Notify only if

Insider Trading

Get notified when an Kinnate Biopharma Inc. insider buys or sells KNTE shares.

Notify only if

News

Receive news related to Kinnate Biopharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNTE